There are also many new targets for precision therapy, such as Bcl-2 family members [36], which could increase chemosensitivity of the tumor, and survival protein kinases such as the HIF1a [37], Src [38] and PI3K [39] pathways. This evidence concerns the gene SRC and neoplasm.